CAR-T

Aleta aims for pivotal US trial with CAR T-cell engager
Clinical Trials Arena
Fri, 09/29/23 - 10:10 am
Aleta Biotherapeutics
CAR-T
ALETA-001
clinical trials
Kite publishes Phase II data for Yescarta in treating B-cell lymphoma
Clinical Trials Arena
Mon, 09/18/23 - 09:53 am
Gilead Sciences
Kite Pharma
Yescarta
clinical trials
CAR-T
relapsed or refractory large B-cell lymphoma
Beam Therapeutics starts dosing in phase 1/2 trial of BEAM-201 in relapsed, refractory T-ALL/T-LL
Benzinga
Tue, 09/5/23 - 11:28 am
Beam Therapeutics
clinical trials
CAR-T
BEAM-201
T-ALL
T-LL
Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T
BioSpace
Mon, 08/21/23 - 08:00 pm
Moderna Therapeutics
CARsgen
MRNA
cancer
cancer vaccine
vaccines
solid tumors
CAR-T
Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans
Fierce Biotech
Mon, 08/21/23 - 10:05 am
Moderna Therapeutics
Claudin18.2
MRNA
vaccines
CAR-T
cancer vaccine
solid tumors
FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death
Fierce Biotech
Tue, 08/15/23 - 10:12 am
Gilead Sciences
Arcellx
CAR-T
cell therapy
FDA
FDA puts 2seventy CAR-T trial on hold in wake of patient death
Fierce Biotech
Mon, 08/14/23 - 10:06 am
2seventy bio
clinical trials
FDA
patient deaths
AML
CAR-T
Regenerative Medicine Challenges Hinder Their Development and Use: GAO
BioSpace
Sun, 07/16/23 - 02:45 pm
regenerative medicine
CAR-T
stem cells
GAO
Caribou Scores Early CAR-T Lymphoma Win, Plans $125M Public Offering
BioSpace
Fri, 07/14/23 - 10:03 am
Caribou Biosciences
CAR-T
CB-010
B-cell non-Hodgkin lymphoma
cell therapy
Pfizer pours $25M investment into Caribou's cell therapies
Fierce Biotech
Thu, 07/6/23 - 10:19 am
Pfizer
Caribou Biosciences
gene editing
CAR-T
Multiple Myeloma
Cartesian maps the path for an autoimmune disease cell therapy
EP Vantage
Fri, 06/23/23 - 09:41 am
Cartesian Therapeutics
MRNA
CAR-T
autoimmune disease
FDA places clinical hold on Arcellx’s multiple myeloma therapy trial
Clinical Trials Arena
Tue, 06/20/23 - 09:57 am
Arcellx
CAR-T
CART-ddBCMA
relapsed or refractory multiple myeloma
FDA
clinical trials
CAR-T beyond cancer? Novartis and others say yes
EP Vantage
Mon, 06/19/23 - 10:19 am
CAR-T
Novartis
Cabaletta Bio
Cartesian Therapeutics
Bristol Myers Squibb
Gracell
Yake Biotechnology
Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma
BioSpace
Fri, 06/16/23 - 09:46 am
Tessa Therapeutics
CAR-T
Hodgkin's lymphoma
TT11X
Death triggers pause of 2seventy CAR-T cell therapy leukemia trial
Fierce Biotech
Wed, 06/14/23 - 10:18 am
2seventy bio
Bluebird Bio
CAR-T
patient death
clinical trials
AML
ASCO 2023: Precigen reports positive early data for CAR-T therapy
BioSpace
Tue, 06/6/23 - 11:12 am
ASCO 2023
Precigen
CAR-T
PRGN-3005
ovarian cancer
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Mon, 06/5/23 - 10:12 am
ASCO 2023
JNJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
China dominates CAR-T therapies
Clinical Trials Arena
Thu, 06/1/23 - 11:25 am
China
cancer
CAR-T
ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?
Fierce Pharma
Fri, 05/26/23 - 09:57 am
ASCO 2023
Bristol Myers Squibb
Breyanzi
CAR-T
CLL
SLL
clinical trials
J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies
BioSpace
Tue, 05/2/23 - 11:46 am
JNJ
Janssen
Cellular Biomedicine
CAR-T
diffuse large B-cell lymphoma

Pages